The COPD multi-dimensional phenotype: A new classification from the STORICO Italian observational study

STORICO study group

Research output: Contribution to journalArticle

Abstract

BACKGROUND: This paper is aimed to (i) develop an innovative classification of COPD, multi-dimensional phenotype, based on a multidimensional assessment; (ii) describe the identified multi-dimensional phenotypes. METHODS: An exploratory factor analysis to identify the main classificatory variables and, then, a cluster analysis based on these variables were run to classify the COPD-diagnosed 514 patients enrolled in the STORICO (trial registration number: NCT03105999) study into multi-dimensional phenotypes. RESULTS: The circadian rhythm of symptoms and health-related quality of life, but neither comorbidity nor respiratory function, qualified as primary classificatory variables. Five multidimensional phenotypes were identified: the MILD COPD characterized by no night-time symptoms and the best health status in terms of quality of life, quality of sleep, level of depression and anxiety, the MILD EMPHYSEMATOUS with prevalent dyspnea in the early-morning and day-time, the SEVERE BRONCHITIC with nocturnal and diurnal cough and phlegm, the SEVERE EMPHYSEMATOUS with nocturnal and diurnal dyspnea and the SEVERE MIXED COPD distinguished by higher frequency of symptoms during 24h and worst quality of life, of sleep and highest levels of depression and anxiety. CONCLUSIONS: Our results showed that properly collected respiratory symptoms play a primary classificatory role of COPD patients. The longitudinal observation will disclose the discriminative and prognostic potential of the proposed multidimensional phenotype. TRIAL REGISTRATION: Trial registration number: NCT03105999, date of registration: 10th April 2017.

Original languageEnglish
Pages (from-to)e0221889
JournalPLoS One
Volume14
Issue number9
DOIs
Publication statusPublished - Jan 1 2019

Fingerprint

observational studies
Chronic Obstructive Pulmonary Disease
Observational Studies
signs and symptoms (animals and humans)
Health
Phenotype
phenotype
quality of life
Quality of Life
Cluster analysis
Factor analysis
dyspnea
anxiety
sleep
Dyspnea
Sleep
Anxiety
Depression
cough
lung function

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Agricultural and Biological Sciences(all)

Cite this

The COPD multi-dimensional phenotype : A new classification from the STORICO Italian observational study. / STORICO study group.

In: PLoS One, Vol. 14, No. 9, 01.01.2019, p. e0221889.

Research output: Contribution to journalArticle

@article{5c33536ac84b40a28f94aeccda02380f,
title = "The COPD multi-dimensional phenotype: A new classification from the STORICO Italian observational study",
abstract = "BACKGROUND: This paper is aimed to (i) develop an innovative classification of COPD, multi-dimensional phenotype, based on a multidimensional assessment; (ii) describe the identified multi-dimensional phenotypes. METHODS: An exploratory factor analysis to identify the main classificatory variables and, then, a cluster analysis based on these variables were run to classify the COPD-diagnosed 514 patients enrolled in the STORICO (trial registration number: NCT03105999) study into multi-dimensional phenotypes. RESULTS: The circadian rhythm of symptoms and health-related quality of life, but neither comorbidity nor respiratory function, qualified as primary classificatory variables. Five multidimensional phenotypes were identified: the MILD COPD characterized by no night-time symptoms and the best health status in terms of quality of life, quality of sleep, level of depression and anxiety, the MILD EMPHYSEMATOUS with prevalent dyspnea in the early-morning and day-time, the SEVERE BRONCHITIC with nocturnal and diurnal cough and phlegm, the SEVERE EMPHYSEMATOUS with nocturnal and diurnal dyspnea and the SEVERE MIXED COPD distinguished by higher frequency of symptoms during 24h and worst quality of life, of sleep and highest levels of depression and anxiety. CONCLUSIONS: Our results showed that properly collected respiratory symptoms play a primary classificatory role of COPD patients. The longitudinal observation will disclose the discriminative and prognostic potential of the proposed multidimensional phenotype. TRIAL REGISTRATION: Trial registration number: NCT03105999, date of registration: 10th April 2017.",
author = "{STORICO study group} and {Antonelli Incalzi}, Raffaele and Canonica, {Giorgio Walter} and Nicola Scichilone and Sara Rizzoli and Lucia Simoni and Francesco Blasi",
year = "2019",
month = "1",
day = "1",
doi = "10.1371/journal.pone.0221889",
language = "English",
volume = "14",
pages = "e0221889",
journal = "PLoS One",
issn = "1932-6203",
publisher = "Public Library of Science",
number = "9",

}

TY - JOUR

T1 - The COPD multi-dimensional phenotype

T2 - A new classification from the STORICO Italian observational study

AU - STORICO study group

AU - Antonelli Incalzi, Raffaele

AU - Canonica, Giorgio Walter

AU - Scichilone, Nicola

AU - Rizzoli, Sara

AU - Simoni, Lucia

AU - Blasi, Francesco

PY - 2019/1/1

Y1 - 2019/1/1

N2 - BACKGROUND: This paper is aimed to (i) develop an innovative classification of COPD, multi-dimensional phenotype, based on a multidimensional assessment; (ii) describe the identified multi-dimensional phenotypes. METHODS: An exploratory factor analysis to identify the main classificatory variables and, then, a cluster analysis based on these variables were run to classify the COPD-diagnosed 514 patients enrolled in the STORICO (trial registration number: NCT03105999) study into multi-dimensional phenotypes. RESULTS: The circadian rhythm of symptoms and health-related quality of life, but neither comorbidity nor respiratory function, qualified as primary classificatory variables. Five multidimensional phenotypes were identified: the MILD COPD characterized by no night-time symptoms and the best health status in terms of quality of life, quality of sleep, level of depression and anxiety, the MILD EMPHYSEMATOUS with prevalent dyspnea in the early-morning and day-time, the SEVERE BRONCHITIC with nocturnal and diurnal cough and phlegm, the SEVERE EMPHYSEMATOUS with nocturnal and diurnal dyspnea and the SEVERE MIXED COPD distinguished by higher frequency of symptoms during 24h and worst quality of life, of sleep and highest levels of depression and anxiety. CONCLUSIONS: Our results showed that properly collected respiratory symptoms play a primary classificatory role of COPD patients. The longitudinal observation will disclose the discriminative and prognostic potential of the proposed multidimensional phenotype. TRIAL REGISTRATION: Trial registration number: NCT03105999, date of registration: 10th April 2017.

AB - BACKGROUND: This paper is aimed to (i) develop an innovative classification of COPD, multi-dimensional phenotype, based on a multidimensional assessment; (ii) describe the identified multi-dimensional phenotypes. METHODS: An exploratory factor analysis to identify the main classificatory variables and, then, a cluster analysis based on these variables were run to classify the COPD-diagnosed 514 patients enrolled in the STORICO (trial registration number: NCT03105999) study into multi-dimensional phenotypes. RESULTS: The circadian rhythm of symptoms and health-related quality of life, but neither comorbidity nor respiratory function, qualified as primary classificatory variables. Five multidimensional phenotypes were identified: the MILD COPD characterized by no night-time symptoms and the best health status in terms of quality of life, quality of sleep, level of depression and anxiety, the MILD EMPHYSEMATOUS with prevalent dyspnea in the early-morning and day-time, the SEVERE BRONCHITIC with nocturnal and diurnal cough and phlegm, the SEVERE EMPHYSEMATOUS with nocturnal and diurnal dyspnea and the SEVERE MIXED COPD distinguished by higher frequency of symptoms during 24h and worst quality of life, of sleep and highest levels of depression and anxiety. CONCLUSIONS: Our results showed that properly collected respiratory symptoms play a primary classificatory role of COPD patients. The longitudinal observation will disclose the discriminative and prognostic potential of the proposed multidimensional phenotype. TRIAL REGISTRATION: Trial registration number: NCT03105999, date of registration: 10th April 2017.

UR - http://www.scopus.com/inward/record.url?scp=85072162631&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85072162631&partnerID=8YFLogxK

U2 - 10.1371/journal.pone.0221889

DO - 10.1371/journal.pone.0221889

M3 - Article

C2 - 31518364

AN - SCOPUS:85072162631

VL - 14

SP - e0221889

JO - PLoS One

JF - PLoS One

SN - 1932-6203

IS - 9

ER -